Literature DB >> 21473635

Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.

Min-Jun Li1, Harry M Greenblatt, Orly Dym, Shira Albeck, Adi Pais, Chidambaram Gunanathan, David Milstein, Hadassa Degani, Joel L Sussman.   

Abstract

Selective estrogen receptor modulators, such as 17β-estradiol derivatives bound to metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of estrogen receptor α ligand-binding domain (ERα-LBD) bound with a novel estradiol-derived metal complex, estradiol-pyridine tetra acetate europium(III), at 2.6 Å resolution. This structure provides important information pertinent to the design of novel functional ERα targeted probes for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473635      PMCID: PMC3112352          DOI: 10.1021/jm200192y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

1.  Chemical and biochemical issues related to X-ray crystallography of the ligand-binding domain of estrogen receptor alpha.

Authors:  S W Goldstein; J Bordner; L R Hoth; K F Geoghegan
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

Review 2.  Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.

Authors:  Ingo Ott; Ronald Gust
Journal:  Anticancer Agents Med Chem       Date:  2007-01       Impact factor: 2.505

Review 3.  Estrogen receptors: how do they signal and what are their targets.

Authors:  Nina Heldring; Ashley Pike; Sandra Andersson; Jason Matthews; Guojun Cheng; Johan Hartman; Michel Tujague; Anders Ström; Eckardt Treuter; Margaret Warner; Jan-Ake Gustafsson
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

4.  Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.

Authors:  Milton T Sonoda; Leandro Martínez; Paul Webb; Munir S Skaf; Igor Polikarpov
Journal:  Mol Endocrinol       Date:  2008-04-10

5.  Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.

Authors:  Leyla Celik; Julie Davey Dalsgaard Lund; Birgit Schiøtt
Journal:  Biochemistry       Date:  2007-01-24       Impact factor: 3.162

6.  Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and release.

Authors:  A C Gee; J A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2001-03

7.  Molecular sensors of estrogen receptor conformations and dynamics.

Authors:  Anobel Tamrazi; Kathryn E Carlson; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2003-08-28

8.  Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging.

Authors:  Chidambaram Gunanathan; Adi Pais; Edna Furman-Haran; Dalia Seger; Erez Eyal; Sarbani Mukhopadhyay; Yehoshoa Ben-David; Gregory Leitus; Hagai Cohen; Ayelet Vilan; Hadassa Degani; David Milstein
Journal:  Bioconjug Chem       Date:  2007-09-05       Impact factor: 4.774

9.  Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.

Authors:  H el Amouri; A Vessières; D Vichard; S Top; M Gruselle; G Jaouen
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  10 in total

1.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

2.  The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands.

Authors:  John A Katzenellenbogen
Journal:  J Med Chem       Date:  2011-07-11       Impact factor: 7.446

3.  In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.

Authors:  Adi Pais; Chidambaram Gunanathan; Raanan Margalit; Inbal Eti Biton; Ady Yosepovich; David Milstein; Hadassa Degani
Journal:  Cancer Res       Date:  2011-10-31       Impact factor: 12.701

4.  Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor.

Authors:  Min Shan; Kathryn E Carlson; Alexander Bujotzek; Anja Wellner; Ronald Gust; Marcus Weber; John A Katzenellenbogen; Rainer Haag
Journal:  ACS Chem Biol       Date:  2013-01-30       Impact factor: 5.100

5.  Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.

Authors:  Adi Pais; Inbal Eti Biton; Raanan Margalit; Hadassa Degani
Journal:  Magn Reson Med       Date:  2012-08-10       Impact factor: 4.668

6.  Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.

Authors:  Berkley E Gryder; Michael K Rood; Kenyetta A Johnson; Vishal Patil; Eric D Raftery; Li-Pan D Yao; Marcie Rice; Bahareh Azizi; Donald F Doyle; Adegboyega K Oyelere
Journal:  J Med Chem       Date:  2013-07-03       Impact factor: 7.446

7.  Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.

Authors:  Hui Wen Ng; Wenqian Zhang; Mao Shu; Heng Luo; Weigong Ge; Roger Perkins; Weida Tong; Huixiao Hong
Journal:  BMC Bioinformatics       Date:  2014-10-21       Impact factor: 3.169

Review 8.  Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands.

Authors:  Hui Wen Ng; Roger Perkins; Weida Tong; Huixiao Hong
Journal:  Int J Environ Res Public Health       Date:  2014-08-26       Impact factor: 3.390

9.  Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.

Authors:  Adi Pais; Hadassa Degani
Journal:  Front Oncol       Date:  2016-04-27       Impact factor: 6.244

10.  Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells.

Authors:  Alexander M Scherbakov; Alexander V Komkov; Anna S Komendantova; Margarita A Yastrebova; Olga E Andreeva; Valerii Z Shirinian; Alakananda Hajra; Igor V Zavarzin; Yulia A Volkova
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.